This revealed that cultured PDX cells at low (passage 3), middle (passage 15) and high (passage 30) passages retained the genomic aberration profiles (e.g. 1p deletion, MYCN amplification and 17q gain) observed in the corresponding patient tumor and xenograft (Fig. 1f). This evidence concerns the gene MYCN and neoplasm.